评估中国小儿喘中奥马利祖马布的价值:一个多标准决策分析
Yuncui Yu1,2, Wang Cao1,2, Yue Xiao3
1Clinical Research Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China.
Healthcare (Basel, Switzerland)
|October 16, 2025
概括
在中国,Omalizumab加标准护理 (SOC) 显示了对儿科中度至重度喘的有条件建议. 这种综合性价值评估偏好了奥马利祖马布+SOC而不是单独的SOC.
科学领域:
- 多标准决策分析 (MCDA) 是一种多标准决策分析.
- 医疗技术评估 (HTA) 是指对医疗技术进行评估.
- 儿科肺病学 儿科肺病学
背景情况:
- 喘是儿童的重要呼吸系统疾病.
- 中度至重度的儿科喘需要先进的治疗选择.
- 评估新疗法的综合价值对于医疗保健决策至关重要.
研究的目的:
- 评估中国儿童中度至重度喘治疗标准护理 (SOC) 之外的奥马利祖马布的综合价值.
- 使用多标准决策分析框架,将奥马利祖马布加SOC与单独的SOC进行比较.
主要方法:
- 一个由17名专家组成的小组使用了分析层次过程 (AHP) 进行MCDA.
- 一个分层的标准系统包括安全性,有效性,经济性,创新性,可访问性和适用性.
- 综合证据来自系统的文献审查和现实世界药监数据 (FAERS).
主要成果:
- 安全性 (38.55%) 和有效性 (28.85%) 获得了专家的最高权重.
- 与SOC单独相比,Omalizumab加SOC在有效性 (2.53比1.94) 和创新 (0.70比0.15) 方面表现出更高的得分.
- 总体估计值高于奥马利祖马布加SOC (7.40分),而不是单独的SOC (7.19分).
结论:
- 在添加到标准护理时,奥马利祖马布是中国中度至重度儿科喘的条件建议策略.
- 该MCDA方法提供了一个综合评估,整合了多个价值领域.
- 进一步的现实世界数据可能会改进治疗建议.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
01:30Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
01:20Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
01:26Asthma-II: Pathophysiology and Classification
4.1K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.1K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.1K
01:26COPD: Management Using Bronchodilators and Corticosteroids
722
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
722